MedPath

Meglumine

Generic Name
Meglumine
Drug Type
Small Molecule
Chemical Formula
C7H17NO5
CAS Number
6284-40-8
Unique Ingredient Identifier
6HG8UB2MUY

Overview

No overview information available.

Indication

适用于泌尿道造影,心血管造影,脑血管造影,其他脏器和周围血管造影,CT增强扫描和其他各种腔道、瘘管造影。但不能用于脑际脊髓造影。

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/02/12
Phase 3
Not yet recruiting
2023/08/25
Phase 2
Not yet recruiting
Hospital Universitário Professor Edgard Santos
2021/12/27
Not Applicable
Completed
Dongzhimen Hospital, Beijing
2021/12/07
Phase 2
Completed
2014/09/09
Phase 4
Completed
2014/01/27
Phase 4
Completed
2013/10/09
Phase 4
Completed
2010/01/15
Early Phase 1
Completed
2008/01/25
Phase 2
Completed
Hospital Universitário Professor Edgard Santos
2007/05/31
Not Applicable
Completed
Combined Military Hospital, Pakistan

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.